Literature DB >> 23378554

Pulmonary hypertension in a patient with hereditary haemorrhagic telangiectasia.

Davinder Chadha1, Ajay Handa, Abhishek Kumar.   

Abstract

A young male patient reported for evaluation of progressive easy fatigability, accompanied by a recent history of recurrent haemoptysis. His clinical examination was unremarkable except for evidence of pulmonary arterial hypertension (PAH). Routine investigations (haemogram, coagulogram, serological tests for connective tissue disorders and a sputum Ziehl Neelsen stain for acid-fast bacilli) were normal. Two-dimensional echocardiography suggested PAH (pulmonary artery systolic pressure-67 mm Hg), whereas the 64-slice spiral CT pulmonary angiogram showed a dilated main pulmonary artery along with bilateral arteriovenous malformations. Cardiac catheterisation performed subsequently confirmed the presence of PAH. On the basis of the above findings, a diagnosis of hereditary haemorrhagic telangiectasia (HHT) complicated with PAH was made, and the patient was started on oral sildenafil therapy to which he responded well. This rare complication of HHT, which requires a high degree of suspicion for diagnosis, is discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23378554      PMCID: PMC3604189          DOI: 10.1136/bcr-2012-008352

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Hereditary hemorrhagic telangiectasia: diagnosis and management.

Authors:  Scott E Olitsky
Journal:  Am Fam Physician       Date:  2010-10-01       Impact factor: 3.292

Review 2.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

3.  Guidelines for the diagnosis and treatment of pulmonary hypertension.

Authors:  N Galiè; M M Hoeper; M Humbert; A Torbicki; J-L Vachiery; J A Barbera; M Beghetti; P Corris; S Gaine; J S Gibbs; M A Gomez-Sanchez; G Jondeau; W Klepetko; C Opitz; A Peacock; L Rubin; M Zellweger; G Simonneau
Journal:  Eur Respir J       Date:  2009-09-12       Impact factor: 16.671

4.  Hereditary hemorrhagic telangiectasia: rare cause of pulmonary hypertension?

Authors:  Rui Providência; Maria do Carmo Cachulo; Gisela Veríssimo Costa; Joana Silva; Carlos Graça Lemos; A M Leitão-Marques
Journal:  Arq Bras Cardiol       Date:  2010-03       Impact factor: 2.000

5.  Successful bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia.

Authors:  Sung-A Chang; Shin Yi Jang; Chang-Seok Ki; I-Seok Kang; Duk-Kyung Kim
Journal:  Heart Vessels       Date:  2010-12-04       Impact factor: 2.037

6.  The intersection of genes and environment: development of pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia and stimulant exposure.

Authors:  Estela Ayala; Kristina T Kudelko; Francois Haddad; Roham T Zamanian; Vinicio de Jesus Perez
Journal:  Chest       Date:  2012-06       Impact factor: 9.410

Review 7.  The pulmonary vascular complications of hereditary haemorrhagic telangiectasia.

Authors:  M E Faughnan; J T Granton; L H Young
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

8.  BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia.

Authors:  Christina M Rigelsky; Constance Jennings; Rainer Lehtonen; Omar A Minai; Charis Eng; Micheala A Aldred
Journal:  Am J Med Genet A       Date:  2008-10-01       Impact factor: 2.802

Review 9.  Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).

Authors:  Vincent Cottin; Sophie Dupuis-Girod; Gaetan Lesca; Jean-François Cordier
Journal:  Respiration       Date:  2007       Impact factor: 3.580

10.  [Pulmonary hypertension in hereditary haemorrhagic teleangiectasia].

Authors:  F Reichenberger; L-E Wehner; A Breithecker; R Voswinckel; O Mensch; R Schulz; H A Ghofrani
Journal:  Pneumologie       Date:  2009-09-29
View more
  4 in total

Review 1.  Optimal management of hereditary hemorrhagic telangiectasia.

Authors:  Neetika Garg; Monica Khunger; Arjun Gupta; Nilay Kumar
Journal:  J Blood Med       Date:  2014-10-15

2.  Pulmonary arteriovenous malformations in children with hereditary hemorrhagic telangiectasia: a longitudinal study.

Authors:  Katie L Mowers; Lynn Sekarski; Andrew J White; R Mark Grady
Journal:  Pulm Circ       Date:  2018-06-19       Impact factor: 3.017

3.  Pulmonary arteriovenous malformations: diagnostic and treatment characteristics.

Authors:  William Salibe-Filho; Bruna Mamprim Piloto; Ellen Pierre de Oliveira; Marcela Araújo Castro; Breno Boueri Affonso; Joaquim Maurício da Motta-Leal-Filho; Edgar Bortolini; Mário Terra-Filho
Journal:  J Bras Pneumol       Date:  2019-06-19       Impact factor: 2.624

4.  The clinical characteristics and long-term prognosis of pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia.

Authors:  Wen Li; Chang-Ming Xiong; Qing Gu; Xiao-Tong Wang; Xiao-Ling Cheng; Li Huang; Tao Yang; Qin Luo; Zhi-Hui Zhao; Xin-Hai Ni; Zhi-Hong Liu; Jian-Guo He
Journal:  Pulm Circ       Date:  2018-02-26       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.